You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • THU0169 Can Baseline (Anti-)Infliximab Serum Trough Levels Predict Successful Down-Titration or Discontinuation of Infliximab in Rheumatoid Arthritis Patients with Long Term Low Disease Activity?

Article metrics

Article menu
Download PDFPDF
Poster Presentation
Rheumatoid arthritis - anti-TNF therapy
THU0169 Can Baseline (Anti-)Infliximab Serum Trough Levels Predict Successful Down-Titration or Discontinuation of Infliximab in Rheumatoid Arthritis Patients with Long Term Low Disease Activity?

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 20143007
Mar 20141001
Apr 20141700
May 20141700
Jun 2014400
Jul 20141800
Aug 2014300
Sep 2014500
Oct 2014702
Nov 2014501
Dec 2014401
Jan 2015600
Feb 2015100
Mar 20151201
Apr 2015901
May 2015400
Jun 2015800
Jul 2015100
Aug 2015300
Sep 2015900
Nov 2015300
Dec 20151000
Jan 20161402
Feb 2016400
Mar 2016400
Apr 2016100
May 2016200
Jun 2016600
Jul 2016600
Aug 2016701
Sep 2016300
Oct 2016800
Nov 2016300
Dec 2016300
Jan 2017500
Feb 2017200
Mar 20172001
Apr 2017400
May 2017700
Jun 2017100
Jul 2017200
Aug 2017400
Sep 2017800
Oct 2017600
Nov 2017800
Dec 20172000
Jan 20182400
Feb 2018800
Mar 20181200
Apr 20181200
May 20182201
Jun 20181200
Jul 20181600
Aug 2018800
Sep 2018600
Oct 2018200
Nov 2018601
Apr 2019200
Jun 2019200
Jul 2019200
Dec 2019300
Feb 20201200
Apr 2020200
May 2020100
Jul 2020200
Aug 2020200
Sep 2020800
Oct 2020200
Nov 2020200
Dec 2020200
Jan 2021200
Feb 2021201
Mar 2021200
Apr 2021400
May 2021100
Aug 2021100
Nov 2021600
Dec 20211200
Jan 2022800
Feb 2022200
Mar 2022500
May 2022400
Jun 2022201
Jul 20221800
Aug 2022900
Sep 2022200
Oct 2022400
Nov 2022400
Dec 2022600
Feb 2023400
Mar 2023200
May 2023400
Jul 2023200
Sep 2023600
Dec 20231000
Mar 2024200
Total628022